meglumine has been researched along with Cancer of Pelvis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbe, C; Bouché, O; Colosio, A; Hoeffel, C; Nguyen, F; Rousset, P; Soyer, P | 1 |
| Carter, WD; Low, RN; Saleh, F; Sigeti, JS | 1 |
| Brix, G; Essig, M; Hawighorst, H; Hoffmann, U; Knapstein, PG; Knopp, MV; Schaeffer, U; van Kaick, G; Zuna, I | 1 |
| Kinkel, K; Lasser, P; Rougier, P; Soyer, P; Spatz, A; Tardivon, AA; Vanel, D | 1 |
| Allkemper, T; Heindel, W; Tombach, B | 1 |
1 trial(s) available for meglumine and Cancer of Pelvis
| Article | Year |
|---|---|
Value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of pelvic recurrence from colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Enhancement; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Pelvic Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2014 |
4 other study(ies) available for meglumine and Cancer of Pelvis
| Article | Year |
|---|---|
Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT.
Topics: Abdominal Neoplasms; Antibodies, Monoclonal; Contrast Media; Drug Combinations; Female; Fluorocarbons; Gadolinium DTPA; Humans; Hydrocarbons, Brominated; Indium Radioisotopes; Magnetic Resonance Imaging; Meglumine; Middle Aged; Oligopeptides; Organometallic Compounds; Ovarian Neoplasms; Pelvic Neoplasms; Pentetic Acid; Peritoneal Neoplasms; Predictive Value of Tests; Prospective Studies; Radioimmunodetection; Sensitivity and Specificity; Tomography, X-Ray Computed | 1995 |
Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium DTPA; Genital Diseases, Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organometallic Compounds; Pelvic Neoplasms; Pentetic Acid; Uterine Cervical Neoplasms | 1996 |
Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients.
Topics: Colon; Colorectal Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fibrosis; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pelvic Neoplasms; Pentetic Acid; Predictive Value of Tests; Prospective Studies; Rectum; Sensitivity and Specificity; Subtraction Technique; Time Factors | 1996 |
[Gd-BOPTA enhanced excretory MR urography without administration of diuretics].
Topics: Adult; Diuretics; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Pelvic Neoplasms; Reproducibility of Results; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urography; Urologic Neoplasms | 2001 |